0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Dermatology a Century Ago |

Dermatitis Dysmenorrhœica Symmetrica

Mark Bernhardt, MD
JAMA Dermatol. 2014;150(10):1043. doi:10.1001/jamadermatol.2014.374.
Text Size: A A A
Published online

Extract

Box Section Ref ID

The Journal of Cutaneous Diseases

October 1914

FURTHER CONTRIBUTIONS ON DERMATOSIS DYSMENORRHŒICA SYMMETRICA (MATZENAUER-POLLAND). R. Polland, p. 260.

Polland takes up the cudgels in defense of the recently described clinical entity of dermatosis dysmenorrhœica symmetrica, and stoutly repudiates the hostile suggestion that the condition is indigenous only to the vicinity of the Graz clinic. A number of very interesting new cases are presented, including a note on the one described by Friedberg in Breslau. The following essential features of the disease are recalled by the descriptions. The disease occurs only in women, presenting the symptoms of abnormal ovarian function, especially menstrual irregularities. A positive lipoid reaction is obtained from the blood, by the method of Neumann and Hermann. The onset occurs suddenly, with subjective symptoms of stinging and burning, and objectively a perifollicular vascular dilatation, with vesicle formation and oozing. In severe cases, follicular infarct-like necroses may develop, with a slough and subsequent scarring. The efflorescences are generally symmetrical, with a tendency to linear configuration on the extremities and a patchy contour on the face. The first appearance tends to be on the latter site, with extension to the body, involution and cyclical reappearance upon the face. Polland regards the condition as incident to a disturbance of the internal secretion of the ovaries and has obtained gratifying therapeutic results in some of his cases from the use of “Ovaradentriferrin.” He feels that there is a circulating toxin among the ætiological factors in the disease, and that the lipoid reaction of the blood supports this contention. A number of cases are cited in elaborating the differential diagnosis between this condition and various herpetiform efflorescences which the author regards as essentially dermal neuroses.

J Cutan Dis. 1914;32(10):724.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

242 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();